TY - JOUR
T1 - Characterization of genome-wide transpositions induced by colistin exposure in multi-drug-resistant Klebsiella pneumoniae
AU - Glingston Rajakani, Sahaya
AU - Xavier, Britto
AU - Nguyen, Ngoc Minh
AU - Lin, Qiang
AU - Plantin, Nienke L.
AU - Wittekamp, Bastiaan H.J.
AU - Zarkotou, Olympia
AU - Van Houdt, Rob
AU - Glupczynski, Youri
AU - Pournaras, Spyros
AU - Bonten, Marc J.M.
AU - Malhotra-Kumar, Surbhi
N1 - Score=10
This study is registered with ClinicalTrials.gov as NCT02208154
PY - 2025/5
Y1 - 2025/5
N2 - Colistin is one of the last-line antibiotics against multi-drug-resistant (MDR) gram-negative pathogens, such as Klebsiella pneumoniae. Using long-read sequencing, we observed remarkable genome-wide transposition events in MDR K. pneumoniae exposed to colistin in patients receiving treatment for respiratory infections or as part of selective decolonization strategies and further confirmed these on in vitro selection experiments. These data add yet another dimension to the role of antibiotics in mediating specific processes in bacteria beyond antibiotic resistance.
AB - Colistin is one of the last-line antibiotics against multi-drug-resistant (MDR) gram-negative pathogens, such as Klebsiella pneumoniae. Using long-read sequencing, we observed remarkable genome-wide transposition events in MDR K. pneumoniae exposed to colistin in patients receiving treatment for respiratory infections or as part of selective decolonization strategies and further confirmed these on in vitro selection experiments. These data add yet another dimension to the role of antibiotics in mediating specific processes in bacteria beyond antibiotic resistance.
KW - Antibiotic resistance
KW - Insertion sequence elements
KW - Colistin
KW - Muti-drug resistant Klebsiella penumoniae
U2 - 10.1128/aac.01574-24
DO - 10.1128/aac.01574-24
M3 - Article
SN - 0066-4804
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
ER -